HIGH RISK STRATEGY EFFICACY IN PROGNOSIS OF PRIMARY ONSET OF ISCHEMIC HEART
https://doi.org/10.15829/1728-8800-2014-6-38-43
Abstract
High morbidity and mortality from ischemic heart disease (CHD) in RF presupposes the significance of individual prognosis of cardiovascular risk and of primary prevention.
Aim. To analyze the level of risk that could be calculated in patients with CHD debut just before the manifest of the disease and therefore to evaluate the opportunities for the CHD debut by standard scores; to evaluate the relation of a real volume of primary prevention events to current Guidelines.
Material and methods. In 122 patients hospitalized with CHD debut as an acute coronary syndrome, a retrospective cardiovascular risk evaluation, which could be found just before the onset of the disease.
Results. The prevalence of traditional risk factors among persons with CHD onset was high: 88% patients had ≥3 risk factors. However, before the onset of acute coronary syndrome 68% patients at Framingham scale and 47% by SCORE could have been under the low and moderate calculated risk that shows low sensitivity for the real CHD risk. Calculated risk by the scores has not correlated with the severity of coronary vessels lesion. In analysis of primary prevention events in was found that in the studied group drug therapy of dyslipidemia was not being performed as primary prevention, though it is indicated by the standards for at least 82% patients.
Conclusion. The data shows that the use of the main risk scores underestimates real chance of CHD development in the exact patient. Also even for the patients, who require statin prescription for the aim of primary prevention, this therapy is not prescribed.
About the Authors
I. S. Skopets
FSBEI HPE Petrozavodsk State University, Petrozavodsk
Russian Federation
Russian Federation
N. N. Vesikova
FSBEI HPE Petrozavodsk State University, Petrozavodsk
Russian Federation
Russian Federation
L. L. Bershtein
SBI HPE North-Western State Medical Univeristy n.a. I.I. Mechnikov of the Ministry of Health, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Camm AJ, Lüscher TF, Serriuys PW. The ESC Textbook of Cardiovascular Medicine. M.: GEOTAR-Media, 2011. Russian (Болезни сердца и сосудов. Руководство Европейского общества кардиологов. Под ред. А. Джона Кэмма, Томаса Ф. Люшера, Патрика В. Серриуса; пер. с англ. под ред. Е.В. Шляхто. М.: ГЭОТАР-Медиа 2011).
2. Oganov RG, Fomina IG. Heart diseases. M.: Litterra 2006. Russian (Болезни сердца: Руководство для врачей. Под ред. Р.Г. Оганова, И.Г. Фоминой. М.: Литтерра 2006).
3. Yakovleva TV. Improving of health care to patients with cardiovascular diseases in the Russian Federation 2013. Russian (Яковлева Т.В. Совершенствование оказания медицинской помощи больным сердечно-сосудистыми заболеваниями в Российской Федерации 2013). http://www.rosminzdrav.ru/health/cardiovascular/97/YakovlevaTV-2.ppt
4. Berstein LL, Katamadze NO, Laznam SS, et al. Individual coronary heart disease prediction as part of primary prevention. Kardiologija 2012; 10: 65-74. Russian (Берштейн Л.Л., Катамадзе Н.О, Лазнам С.С. и др. Индивидуальное прогнозирование риска развития ишемической болезни сердца в рамках первичной профилактики. Кардиология 2012; 10: 65-74).
5. Britov AN, Pozdnyakov JuM, Volkova JeG, et al. Cardiovascular prevention. National guidelines. Cardiovascular Treatment and Prevention 2011; 6 annex 2: 1-64. Russian (Бритов А.Н., Поздняков Ю.М., Волкова Е.Г. и др. Кардиоваскулярная профилактика. Национальные рекомендации. Кардиоваскулярная терапия и профилактика 2011; 6 Приложение 2: 1-64).
6. Kovalenko VN. Cardiology. K. MORION, 2008. Russian (Коваленко В.Н. Руководство по кардиологии — К. МОРИОН, 2008).
7. Braunwald’s heart disesase: a textbook of cardiovascular medicine, Peter Libby, et al. Russian (Болезни сердца по Браунвальду: руководство по сердечно-сосудистой медицине. Под ред. П. Либби и др.; пер. с англ., под общ.ред. Р.Г. Оганова. В 4 т. Том 3: главы 38-60. М.: Логосфера, 2013).
8. Matheny M, McPheeters ML, Glasser A, et al. Systematic review of cardiovascular disease risk assessment tools. Vanderbilt Evidence-based Practice Center 2011.
9. Wattanasuwan N, Khan IA, Gowda RM, et al. Effect of acute myocardial infarction on cholesterol ratios. Chest 2001;120:1196.
10. Chazova IE, Bojtsov SA, Nebieridze DV, et al. Arterial hypertension diagnosis and treatment. National guidelines. Cardiovascular Treatment and Prevention 2008; 7 (6) annex 2. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертензии Кардиоваскулярная терапия и профилактика 2008; 7 (6) Приложение 2).
11. Jerlih AD, Gracianskij NA. Acute coronary syndrom without ST-segment elevation in Russian hospitals actual clinical practice. Comparative data of registers “RECORD-2” vs “RECORD”. Kardiologija 2012; 10: 9-16. Russian (Эрлих А.Д. Грацианский Н.А. Острый коронарный синдром без подъемов ST в реальной практике российских стационаров. Сравнительные данные регистров “РЕКОРД-2” и “РЕКОРД”. Кардиология 2012; 10: 9-16).
12. Vasan RS, Sullivan LM, Peter WF, et al. Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors. Ann Intern Med 2005; 142: 393-402.
13. Tanaka A, Shimada K, Namba M, et al. Relationship between longitudinal morphology of ruptured plaques and TIMI flow grade in acute coronary syndrome: a threedimensional intravascular ultrasound imaging study. Eur Heart J 2008; 29: 38-44.
14. Ganelina IE. Coronory arteries atherosclerosis and ischemic heart disesase. SPb.: Izdatel’stvo SZGMU im. I.I. Mechnikova 2012. Russian (Атеросклероз венечных артерий и ишемическая болезнь сердца.— 2-е изд., перераб. и доп. / под ред. И.Е. Ганелиной. СПб.: Издательство СЗГМУ им. И.И. Мечникова 2012).
15. Katamadze NO, Berstein LL, Grishkin YuN. Subclinical atherosclerosis imaging as a component of a comprehensive strategy for cardiovascular risk stratification. Cardiovascular Treatment and Prevention 2012; 2: 76-84. Russian (Катамадзе Н.О., Берштейн Л.Л., Гришкин Ю.Н. Диагностика субклинического атеросклероза как элемент современной стратегии стратификации сердечно-сосудистого риска. Кардиоваскулярная терапия и профилактика 2012; 2: 76-84).
16. Dent TH. Predicting the risk of coronary heart disease I. The use of conventional risk markers. Atherosclerosis 2010; 213(2): 345-51.
17. Chepurina NA, Shal’nova SA, Deev AD. Prognostic value of total cardiovascular risk and the factors determining it: 10 year observation of men, state employees. Cardiol and cardiovascular surgery 2009; 1: 15-20. Russian (Чепурина Н.А., Шальнова С.А., Деев А.Д. Прогностическая значимость суммарного риска сердечно-сосудистых заболеваний и факторов, его определяющих: 10-летнее наблюдение выборки мужчин — государственных служащих. Кардиол и серд-сосуд хир 2009; 1: 15-20).
18. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary. Ann Intern Med 2009; 150: 474-84.
19. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-45.
20. Ridker P, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 2007; 297(6): 611-9.
Review
For citations:
Skopets I.S., Vesikova N.N., Bershtein L.L. HIGH RISK STRATEGY EFFICACY IN PROGNOSIS OF PRIMARY ONSET OF ISCHEMIC HEART. Cardiovascular Therapy and Prevention. 2014;13(6):38-43. (In Russ.) https://doi.org/10.15829/1728-8800-2014-6-38-43
Views:
992
Email this article 
